Biocant Park

Biocant Park Overview

Investor Type Accelerator/​Incubator
Investments 39
Portfolio 28
Exits 3
Exits

Biocant Park General Information

Description

Founded in 2009, Biocant Park is a Portuguese Science and Technology Park entirely devoted to Biotechnology. The firm originated a dynamic research and business environment rarely seen in this sector in Portugal, perfect for innovation and knowledge exploitation. The companies at the firm represent around 40% of the total national number of biotech companies. The firm provides a wide variety of services and opportunities to develop a competitive business. Companies in the park share a high degree of internationalization of their activities and skilled human resources.

Contact Information

Website
Year Founded
2009
Primary Investor Type
Accelerator/Incubator
Other Investor Types
Growth/Expansion
Venture Capital
Primary Office
  • Portugal
+351 231 000 000

Biocant Park Investments (39)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Coimbra Genomics 01-Jan-2021 Later Stage VC Decision/Risk Analysis Generating Revenue
000000 01-Jan-2021 00000 00000 Biotechnology Generating Revenue
00000 01-Jan-2021 00000 00000 Business/Productivity Software Generating Revenue
000000000 01-Oct-2020 00000 00000 Biotechnology Product Development
000000 00 00000 01-Jan-2019 000000000000 Biotechnology Startup
00000000 000000000 10-Dec-2015 00000 00000 00000 Biotechnology Out of Business
00000 05-Nov-2015 0000 00000 00000 Business/Productivity Software Generating Revenue
00000 0 01-Jan-2010 000000000000 Drug Delivery Generating Revenue
Crioestaminal 01-Jan-2007 PE Growth/Expansion Biotechnology Profitable
Biotrend 27-Jun-2005 Seed Round Biotechnology Generating Revenue
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocant Park Exits (3)

To view Biocant Park‘s complete exit history, request access >>
Company Name Exit Date Exit Type Exit Size
Exogenus Therapeutics 01-Oct-2019 Out of Business
0000000000000 01-Sep-2018 000000000000000000 000.00
00000000 30-May-2018 000000000000000000

Biocant Park Team (2)

Name Title Deals Funds Boards Office
João Neto Chief Executive Officer Portugal
Tenke Zoltani Investment Advisor & shareholder 0 Geneva, Switzerland